Our future projects are now directed to investigate the molecular mechanisms by which Gdpd3-mediated lysophospholipid metabolism and TGFβ-FOXO signalling cooperate to support CML stemness in vivo. The gene discussed is GDPD3; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.